Regeneron Pharmaceuticals, Inc.
Angiopoietin-based interventions for treating cerebral malaria

Abstract:

The present invention provides methods for treating, preventing or reducing the severity of cerebral malaria. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising a modified angiopoietin molecule such as AngF1-Fc-F1.